Heykants J - Search Results

1

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.

Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J. Snoeck E, et al. Among authors: heykants j. Psychopharmacology (Berl). 1995 Dec;122(3):223-9. doi: 10.1007/BF02246543. Psychopharmacology (Berl). 1995. PMID: 8748391 Clinical Trial.

2

Absorption, metabolism, and excretion of risperidone in humans.

Mannens G, Huang ML, Meuldermans W, Hendrickx J, Woestenborghs R, Heykants J. Mannens G, et al. Among authors: heykants j. Drug Metab Dispos. 1993 Nov-Dec;21(6):1134-41. Drug Metab Dispos. 1993. PMID: 7507814

3

The pharmacokinetics of risperidone in humans: a summary.

Heykants J, Huang ML, Mannens G, Meuldermans W, Snoeck E, Van Beijsterveldt L, Van Peer A, Woestenborghs R. Heykants J, et al. J Clin Psychiatry. 1994 May;55 Suppl:13-7. J Clin Psychiatry. 1994. PMID: 7520903

4

Plasma protein binding of risperidone and its distribution in blood.

Mannens G, Meuldermans W, Snoeck E, Heykants J. Mannens G, et al. Among authors: heykants j. Psychopharmacology (Berl). 1994 May;114(4):566-72. doi: 10.1007/BF02244986. Psychopharmacology (Berl). 1994. PMID: 7531854

5

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

Huang ML, Van Peer A, Woestenborghs R, De Coster R, Heykants J, Jansen AA, Zylicz Z, Visscher HW, Jonkman JH. Huang ML, et al. Among authors: heykants j. Clin Pharmacol Ther. 1993 Sep;54(3):257-68. doi: 10.1038/clpt.1993.146. Clin Pharmacol Ther. 1993. PMID: 7690693

6

Absorption, metabolism and excretion of ketanserin in man after oral administration.

Meuldermans W, Hendrickx J, Woestenborghs R, Van Peer A, Lauwers W, De Cree J, Heykants J. Meuldermans W, et al. Among authors: heykants j. Arzneimittelforschung. 1988 Jun;38(6):789-94. Arzneimittelforschung. 1988. PMID: 3178919

7

The metabolism and excretion of risperidone after oral administration in rats and dogs.

Meuldermans W, Hendrickx J, Mannens G, Lavrijsen K, Janssen C, Bracke J, Le Jeune L, Lauwers W, Heykants J. Meuldermans W, et al. Among authors: heykants j. Drug Metab Dispos. 1994 Jan-Feb;22(1):129-38. Drug Metab Dispos. 1994. PMID: 7512019

8

Pharmacokinetics of orally administered levocabastine in patients with renal insufficiency.

Zazgornik J, Huang ML, Van Peer A, Woestenborghs R, Heykants J, Stephen A. Zazgornik J, et al. Among authors: heykants j. J Clin Pharmacol. 1993 Dec;33(12):1214-8. doi: 10.1002/j.1552-4604.1993.tb03922.x. J Clin Pharmacol. 1993. PMID: 7907347

9

The pharmacokinetic properties of topical levocabastine. A review.

Heykants J, Van Peer A, Van de Velde V, Snoeck E, Meuldermans W, Woestenborghs R. Heykants J, et al. Clin Pharmacokinet. 1995 Oct;29(4):221-30. doi: 10.2165/00003088-199529040-00002. Clin Pharmacokinet. 1995. PMID: 8549024 Review.

10

The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine.

Snoeck E, Jacqmin P, Van Peer A, Danhof M, Ver Donck K, Van Belle H, Woestenborghs R, Crabbé R, Van Gool R, Dupont A, Heykants J. Snoeck E, et al. Among authors: heykants j. Br J Clin Pharmacol. 1996 Nov;42(5):605-13. doi: 10.1111/j.1365-2125.1996.tb00116.x. Br J Clin Pharmacol. 1996. PMID: 8951192 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters